Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Environmental Health PHGKB

Specific PHGKB|Environmental Health PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

Last Posted: Apr 17, 2024
spot light Spotlight

Many roads to a gene-environment interaction.
Kenneth E Westerman et al. Am J Hum Genet 2024 4 (4) 626-635 (Posted Apr 10, 2024 8AM)

From the abstract: "Despite the importance of gene-environment interactions (GxEs) in improving and operationalizing genetic discovery, interpretation of any GxEs that are discovered can be surprisingly difficult. There are many potential biological and statistical explanations for a statistically significant finding and, likewise, it is not always clear what can be claimed based on a null result. Here, we provide a detailed explanation of five “phenomena,” or data-generating mechanisms, that can lead to nonzero interaction estimates, as well as a discussion of specific instances in which they might be relevant. "

Challenges and opportunities for Lynch syndrome cascade testing in the United States.
Lauren E Passero et al. Fam Cancer 2024 3 (Posted Apr 02, 2024 10AM)

From the abstract: " Lynch syndrome is an underdiagnosed genetic condition that increases lifetime colorectal, endometrial, and other cancer risk. Cascade testing in relatives is recommended to increase diagnoses and enable access to cancer prevention services, yet uptake is limited due to documented multi-level barriers. Individual barriers such as feelings of fear, guilt, and anxiety and limited knowledge about Lynch syndrome as well as interpersonal barriers including complex family dynamics and language barriers limit family communication about Lynch syndrome and prevent uptake of genetic screening for relatives. Organizational and environmental barriers including a shortage of genetics professionals, high costs, and fears of discrimination also reduce cascade testing. These multi-level barriers may disproportionately impact underserved populations in the United States,"

Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.
Fulya Akçimen et al. Nat Rev Genet 2023 4 (9) 642-658 (Posted Mar 27, 2024 1PM)

From the abstract: "Recent advances in sequencing technologies and collaborative efforts have led to substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS). This momentum has, in turn, fostered the development of putative molecular therapies. In this Review, we outline the current genetic knowledge, emphasizing recent discoveries and emerging concepts such as the implication of distinct types of mutation, variability in mutated genes in diverse genetic ancestries and gene–environment interactions. "

Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
Benjamin Cross et al. Pharmacogenomics J 2024 3 (2) 7 (Posted Mar 12, 2024 0PM)

From the abstract: "This review seeks to highlight the genetic, environmental and clinical factors associated with variability in anticoagulant response, and review the current evidence base for tailoring the drug, dose, and/or monitoring decisions to identified patient subgroups to improve anticoagulant safety. Areas that would benefit from further research are also identified. Validated variants in VKORC1, CYP2C9 and CYP4F2 constitute biomarkers for differential warfarin response and genotype-informed warfarin dosing has been shown to reduce adverse clinical events. "


news Latest News and Publications
Comparative Analysis of Clinical Outcomes Using Propensity Score Matching: Coronavirus Disease 2019 vs. Seasonal Influenza in Korea. External Web Site Icon
Sim Jae Kyeom, et al. Journal of Korean medical science 2024 0 0. (14) e128
Computational methods in the analysis of SARS-CoV-2 in mammals: A systematic review of the literature. External Web Site Icon
Paula Vitória Silva et al. Comput Biol Med 2024 4 108264
Group A Streptococcus pyogenes in wastewater: Applicability of wastewater-based epidemiology for monitoring the prevalence of GAS pharyngitis during the late COVID-19 pandemic phase. External Web Site Icon
Shrestha Sadhana, et al. The Science of the total environment 2024 0 0. 172447
Machine learning insights into PM changes during COVID-19 lockdown: LSTM and RF analysis in Mashhad. External Web Site Icon
Moezzi Seyed Mohammad Mahdi, et al. Environmental monitoring and assessment 2024 0 0. (5) 453
CovMediScanX: A medical imaging solution for COVID-19 diagnosis from chest X-ray images. External Web Site Icon
Nair Smitha Sunil Kumaran, et al. Journal of medical imaging and radiation sciences 2024 0 0.
Predicting outcomes of the acute phase of COVID-19. High sensitive prognostic model, based on the results of the international registry "analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients" (ACTIV). External Web Site Icon
Arutyunov Gregory P, et al. Heliyon 2024 0 0. (7) e28892
Transit communication via Twitter during the COVID-19 pandemic. External Web Site Icon
Zhang Wenwen, et al. Environment and planning. B, urban analytics and city science 2024 0 0. (5) 1244-1261
Using mobile phone big data to discover the spatial patterns of rural migrant workers' return to work in China's three urban agglomerations in the post-COVID-19 era. External Web Site Icon
Liu Kai, et al. Environment and planning. B, urban analytics and city science 2024 0 0. (4) 878-894
Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates. External Web Site Icon
Rochelle H Holm et al. Commun Med (Lond) 2024 4 (1) 70
First Molecular Detection of SARS-CoV-2 in Sewage and Wastewater in Ghana. External Web Site Icon
Ewurabena Oduma Duker et al. Biomed Res Int 2024 4 9975781
COVID-19 outbreak at a residential apartment building in Northern Ontario, Canada. External Web Site Icon
Dinna Lozano et al. Epidemiol Infect 2024 3 e53
Emerging threat: Antimicrobial resistance proliferation during epidemics - A case study of the SARS-CoV-2 pandemic in South Brazil. External Web Site Icon
Marques Raizza Zorman, et al. Journal of hazardous materials 2024 0 0. 134202
Validated machine learning tools to distinguish checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis. External Web Site Icon
Hindocha Sumeet, et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 0 0. 110266
Soft interface confined DNA walker for sensitive and specific detection of SARS-CoV-2 variants. External Web Site Icon
Wang Zhangmin, et al. Talanta 2024 0 0. 126009
Use of artificial intelligence to develop predictive algorithms of cough and PCR-confirmed COVID-19 infections based on inputs from clinical-grade wearable sensors. External Web Site Icon
Walter Jessica R, et al. Scientific reports 2024 0 0. (1) 8072
A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care. External Web Site Icon
Kaitlyn M Wojcik et al. J Cancer Surviv 2024
Environmental Surveillance of Flood Control Infrastructure Impacted by Unsheltered Individuals Leads to the Detection of SARS-CoV-2 and Novel Mutations in the Spike Gene External Web Site Icon
Harrington A, et al. Environ Sci Technol Lett. Apr 3, 2024.
Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland. External Web Site Icon
Anssi Lipponen et al. Sci Rep 2024 4 (1) 7751
Contemporary attitudes and beliefs on coronary artery calcium from social media using artificial intelligence. External Web Site Icon
Sulaiman Somani et al. NPJ Digit Med 2024 7(1) 83
PRERISK: A Personalized, Artificial Intelligence-Based and Statistically-Based Stroke Recurrence Predictor for Recurrent Stroke. External Web Site Icon
Giorgio Colangelo et al. Stroke 2024

More


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP